Tourmaline Bio
TRML
TRML
84 hedge funds and large institutions have $272M invested in Tourmaline Bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
42% less capital invested
Capital invested by funds: $470M → $272M (-$198M)
80% less call options, than puts
Call options by funds: $213K | Put options by funds: $1.05M
Holders
84
Holding in Top 10
3
Calls
$213K
Puts
$1.05M
Top Buyers
| 1 | +$32.7M | |
| 2 | +$15.8M | |
| 3 | +$4.27M | |
| 4 |
Morgan Stanley
New York
|
+$4.01M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.78M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$28.6M | |
| 3 | -$20.8M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$10.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$7.35M |